UBS
UBS Group AG
$55.38-0.54%
Setup
Near pivot
Buy Zone
$55.99-$58.79
Sector
Banks - Diversified
Industry
Banks - Diversified
44
Recommendation
Avoid
Avoid
Too many CANSLIM criteria failing.
UBS chart
Loading chart…
ADX
Developing26.1Long Term
Up ↑Intermediate Term
Up ↑Short Term
Up ↑Overall Quality44
RS Rating
71
relative strength
Fundamentals
50
Weak fund-Q
Volume Demand
45
-39% vs avg
Technical Setup
88
7/8 checks
Industry/Theme
91
Banks - Diversified
Trade Plan
Avoid
Entry
$55.99
Entry Zone
$55.99-$58.79
Stop / Risk
$51.51
RS Rating
71
Volume confirmed
No
Targets
$67.19 / $69.99
Breakout · IBD Setup
5 ✓ 3 ✗
Entry $55.99–$58.79Stop $51.51Target $67.19 / $69.99
Market regimeUptrend
Quality44
RS Rating71
Above 50-MA+4.66%
Above 200-MA+21.27%
VolumeWeak
In Buy ZoneYes
Not extendedOK
Invalidation · Close below stop
How this came together
44
MarketUptrend
SetupNear pivot
ConfidenceExperimental · not backtested
Fund-Q50 · Weak
StatusAvoid
Stock Data
52-Week Range36 – 56
Price % Chg YTD21.13%
Price % Chg 4wk4.81%
50-Day Avg Vol1.9 Mil
P/E Ratio18.8
Market Cap$170B
SectorFinancial
IndustryBanks - Diversified
Company Fundamentals
EPS % Chg (Qtr)20.75%
Sales % Chg (Qtr)4.32%
EPS Growth 5y6.13%
Sales Growth 5y19.62%
Annual ROE10.67%
Gross Margin—
Operating Margin13.97%
Net Margin11.82%
Debt / Equity4.52
Setup levels
Current price
$55.38
Pivot
$55.99
Distance to buy
-1.1%
52-week range
35.83-55.98
Trigger evidence
No active trigger evidence available.
Pattern levels: pivot 55.99
Financial health checks
3/5
Return on equity above 15%
ROE 10.67%
Net margin above 10%
Net margin 11.82%
EPS growing quarter on quarter
EPS q/q 20.75%
Sales growing quarter on quarter
Sales q/q 4.32%
Debt to equity below 1.0
D/E 4.52
Key metrics
Finviz snapshot · value vs. sector median (≥5 peers)
Annual ROE10.67%
vs sector -3.5%
Net margin11.82%
vs sector -7.8%
Gross margin—
EPS growth q/q20.75%
vs sector -11.7%
Sales growth q/q4.32%
vs sector -12.3%
Debt / equity4.52
vs sector +1.47
Business quality
50
GradeWeak
EPS rating47
P/E18.8
Market cap$170B
IndustryBanks - Diversified
Technical checks
Über 50-MA
Pass
Über 200-MA
Pass
RS-Linie auf neuem Hoch
Pass
Volumen bestätigt
Fail
In Kaufzone
Pass
Nicht überextended
Pass
Über 21-EMA
Pass
Volumen gesund
Pass
IBD / source mentions
No recent IBD mention found for this ticker.
Signal history
Added to list
2026-09-02
Trigger date
—
Days on list
5
Data sources: internal CANSLIM engine · Finviz snapshot · TradingView chart. Not investment advice.